Anti-coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis
Field | Value | Language |
dc.contributor.author | Wyld, M | |
dc.contributor.author | Clayton, P | |
dc.contributor.author | Morton, Rachael L | |
dc.contributor.author | Chadban, S | |
dc.date.accessioned | 2016-01-27 | |
dc.date.available | 2016-01-27 | |
dc.date.issued | 2013-11-26 | |
dc.identifier.citation | 8. Wyld ML, Clayton PA, Morton RL, Chadban SJ. Anti-coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis. Nephrology (Carlton). 2013 Dec;18(12):783-9. doi: 10.1111/nep.12170. | en_AU |
dc.identifier.uri | http://hdl.handle.net/2123/14289 | |
dc.description.abstract | None | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | Wiley | en_AU |
dc.subject | health economics | en_AU |
dc.title | Anti-coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis | en_AU |
dc.type | Article | en_AU |
dc.type.pubtype | Post-print | en_AU |
Associated file/s
Associated collections